Navigation Links
Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
Date:12/14/2010

atters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX2931 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... , 27 de octubre de 2014 /PRNewswire/ ... menudo conocida como ardor de estómago, es un ... mundo. [1] La elección de alimentos [2] ... un impacto en los síntomas de la GERD. ... ayudar a las personas a gestionar los síntomas ...
(Date:10/27/2014)... -- In the last few weeks, Ebola has gone from a localized ... a worldwide crisis when a traveler to United States ... nurses were infected. While much of the cable news ... technology, such as electronic health records (EHRs), to help find, combat, ... Healthcare Editor Alison Diana fills in those gaps by ...
(Date:10/27/2014)... Mass. , Oct. 27, 2014  OMNIlife science™, ... billion global hip and knee replacement device market, announced it ... replacement technology at the American Association of Hip and ... Dallas Hotel in Dallas, Texas ... Bronze corporate partner of the organization. ...
Breaking Medicine Technology:Trate los síntomas del reflujo gracias a la Food4GERD App 2Trate los síntomas del reflujo gracias a la Food4GERD App 3Trate los síntomas del reflujo gracias a la Food4GERD App 4EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3
... Texas, Nov. 18, 2010 OCuSOFT, Inc., an ... to announce that ZYTAZE™ is now available in ... but are not limited to: Walgreens, CVS, Wal-Mart, ... In an early pilot study, ZYTAZE™ demonstrated marked ...
... FORD, Pa., Nov. 18, 2010 Endo Pharmaceuticals Holdings ... it priced $400 million aggregate principal amount of 7.00% ... of 99.10 percent in connection with its previously announced ... of the Company and will be guaranteed by certain ...
Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes 2
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... of three West African nations ravaged by the disease -- ... Dr. Bruce Aylward, WHO,s assistant director general, said there,s been ... no increase in laboratory-confirmed cases. He said he was cautiously ... be making some progress, The New York Times ...
(Date:10/30/2014)... October 30, 2014 Global prebiotics market ... according to a new study by Grand View Research, ... demand for sugar and fat free products owing to ... demand for prebiotics over the forecast period. , View ... , Food & beverage was the largest application segment ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
(Date:10/30/2014)... who used stem cells to create miniature human stomachs ... new way to learn more about the development and ... pluripotent stem cells -- which can become any type ... functional miniature stomachs, to study infection by H. ... stomach cancer. The miniature stomachs offer many research ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... Senior,Services has expanded into the San Joaquin County, California ... Response Company, is proud to announce seniors in San ... Services for outstanding,care. For over a decade, a caring ... sincere concern for the betterment of life that goes ...
... Donor Centers, LENEXA, Kan., Oct. 31 ... provider of ClosedLoop(TM) clinical,systems for blood and medication ... of substantially all of the assets of Integrated,Marketing ... products and,services that enable blood and plasma donation ...
... (NYSE: BSX ) announced today that a jury ... Boston Scientific infringes a patent of,Cordis Corporation, a subsidiary ... Company said it believes the finding of infringement is,in ... overturn it. No damages were determined because the ...
... MEMPHIS, Tenn., Oct. 31 Mrs. Vivian,Berryhill will ... Global Summit,on AIDS and the Church, at Saddleback ... president of the National Coalition of Pastors,Spouses (NCPS), ... whose mission is to raise health awareness in,communities ...
... chiropractic,and five friends of chiropractic were honored with ... State Convention on,October 21, 2007 at the Doubletree ... their chiropractic colleagues and peers., In recognition ... profession in Colorado, the following individuals received,these prestigious ...
... the scientific journal Genome Research ( www.genome.org ) ... domestic cat genome ( Felis catus ). , ... well-documented lineage can be traced back several generations to Sweden, ... that are currently being analyzed using light (two-fold) genome sequence ...
Cached Medicine News:Health News:Announcing Always Best Care Senior Services Expansion Into San Joaquin County, California 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 3Health News:Boston Scientific Announces Verdict in Cordis Litigation 2Health News:Boston Scientific Announces Verdict in Cordis Litigation 3Health News:Head of Pastors' Spouses to Challenge Women at Saddleback's Global Summit on AIDS and the Church 2Health News:Colorado Doctors of Chiropractic Win Awards 2Health News:Domestic cat genome sequenced 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... lightweight brace is designed for the ... fractures. The anatomically correct design achieves ... for optimal control of ulnar segments. ... motion is permitted to prevent problems ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
... joint or DIP joint flexioncontractures of any degree. ... gel-lining cushions injured fingers so treatment to straighten ... more successful therapy results. Use during the day ... maintain gains in motion. Available in small, medium ...
Medicine Products: